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1. Introduction
  The treatment of bone nonunion, bone defects caused 
by trauma and the limb salvage treatment of bone tumors, 
even some of the bone reconstruction surgery is often 
related to bone graft. Extensive bone injuries that require 
grafting typically involve one of two kinds of bone material: 
autograft or allograft.
  Autograft and allograft are traditional options for treatment 
of larger bone defects[1,2], however, their use is associated 
with several disadvantages. Autograft is considered to 
be more effective but it requires another operation with 
additional loss of blood and a prolonged anesthetic time. It 
Objective: To explore effect of calcium citrate on bone integration in a rabbit femur defect model, 
and to compare the bone formation with different sizes by radiological and histological study. 
Methods: Twenty-four male Japanese white rabbits were randomly divided into three groups 
(Group A, B, C) in this study. Under anesthesia, defects of four sizes (1.2, 1.5, 2.0 and 2.5 mm) 
were created in each of the rabbits. Commercially pure calcium citrate powder was placed inside 
the medullary compartment of the femur (Experimental), while in the contralateral femur (Control) 
nothing was implanted. The defects were analyzed using radiography and histological analysis 
by using Imagepro-Plus 6.0 software after animal was sacrificed at 4th(Group A), 6th(Group B) 
and 8th(Group C) weeks postoperatively. Four samples were analyzed for each size of defect and 
each healing period. Results: The histological and the radiologic evaluation were performed after 
sacrification of all rabbits on postoperative 4th and 6th weeks, It showed significant difference 
between the experimental group and the control group when these defects were less than or equal 
to 2.0 mm. No statistical difference was observed when these defects were larger than 2.0 mm at 
all healing periods except at the 4th week. Conclusions: Calcium citrate affects the early periods 
of bone defects healing mechanism in Japanese white rabbits positively, especially when the 
defect is not too large. We suggest further studies on calcium citrate to determine the effects of 
various dosages, administration ways and the experimental time on the bone defects.
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may also lead to donor site complications like neurovascular 
injury, infection, hematoma formation and chronic pain[3-5], 
which is of limited availability and carry the possibility 
of donor site morbidity[1,2]. Allograft and xenograft bone 
substitutes have been studied to overcome the risks 
associated to autogenous bone, but their use is complicated 
by issues such as immunogenicity and consequent 
rejection, graft sequestration, infection, and the potential for 
disease transmission[1,2]. Considering all these limitations, 
alloplastic grafts appears to be safe and convenient[6-11], 
and synthetic grafts are preferred in place of autologous 
grafts. Various studies have proved the efficacy of calcium 
citrate as a substitute for an autologous graft. Calcium 
citrate appears to be the most appropriate when a bone 
substitute with some mechanical strength is needed, as 
calcium citrate is composed of the natural minerals found 
in human bone and it is similar with the natural structure of 
cancellous bone. Calcium citrate is a biocompatible material 
with osteoconductive properties. It is available in various 
forms and the bone formation and graft incorporation varies 
according to the type.
  The aim of the present study was to prepare calcium citrate 
and explore its effect on bone integration in a femur defect 
rabbit model. We investigated the bone formation with 
different sizes of holes and compared them by radiological 
and histological study.
2. Materials and methods
2.1. Animals and reagent
  Twenty-four healthy male Japanese white rabbits weighing 
between 2.0-3.5 kg were used as experimental animals for 
the study. All the rabbits were divided into three groups 
(Group A, B, C) randomly. Before the study, general health of 
the rabbits was monitored for 7 days. The rabbits were kept 
in standard cages in an experimental animal room and were 
fed with a standard laboratory diet and water. This study 
protocol was approved by the ethical committee for animal 
experiments of Wenzhou Medical College, Zhejiang, China.
  The calcium citrate was purchased from Sigma.
2.2. Surgical procedure
 All the animals were anesthetized by intraperitoneal 
administration with 10% trichloroacetaldehyde monohydrate, 
at a dose of 3 mL per 1 kg body weight. The skin was 
disinfected and shaved; the shaved and disinfected incision 
site was treated topically with 1% lingocaine solution. After 
administering local anesthetic, a longitudinal incision of 
4 cm was made along the frontal aspect of both femurs. 
Subcutaneous tissue, muscles and ligaments were dissected 
to expose the external surface of the femur in the area of the 
diaphyseal bone. Kirschner wire with different sizes (1.2 mm,
1.5 mm, 2.0 mm, 2.5 mm in diameter) were used to drill holes 
reaching the bone marrow. Overheating and additional bone 
damage was prevented by using cooling saline.
  Calcium citrate powder (15 mg) was placed inside the 
medullary compartment of the femur (Experimental), while 
in the contralateral femur (Control) nothing was implanted. 
The wounds were carefully sutured. The animals were given 
800 000 u penicillin intramuscular injections every 12 hours 
for the first 48 hours after the operation. Within 2-3 days, 
the animals resumed normal ambulation and did not show 
signs of pain or distress. 
  The animals were killed by ether overdose, at 4th(Group 
A), 6th(Group B) and 8th(Group C) weeks postoperatively. 
The femur were resected, fxed in 10% formalin solution and 
radiographed. 
2.3. Evaluation
2.3.1. X-ray examination
  X-ray photographys were taken at 4th, 6th and 8th weeks 
postoperatively.
2.3.2. Histological analysis
  All histological procedures and evaluations were carried 
out in the Laboratory of Orthopaedic Research Institute and 
Scientific Research Center of Second Affiliated Hospital 
of Wenzhou Medical College. Hard tissue samples were 
fixed with 10% buffered formalin for 24-72 hours and 
decalcified with 10% formic acid for 3 weeks. After washing 
under tap water overnight, samples were embedded in 
paraffin. Three sections with 4 毺m thickness were cut at 
the central region of each specimen to obtain maximum 
standardization of the cutting surface. All sections were 
xyelene deparaffinized at 56 ℃, then incubated in absolute 
96% ethanol. For histomorphological evaluation, sections 
were stained with routine hematoxylin-eosine. Routine 
histology and histomorphometric analyses were performed 
using transmission light microscopy (Axioskop Carl Zeiss 
GmbH, Jena, Germany) and image-analysis software (KS 
300; Kontron Electronic GmbH, Munchen, Germany). 
  The bone area ratio was estimated by analyzing the newly 
formed bone in compact bone area and counting total 
dot numbers with an image analyzing software (Image J, 
National Institute of Health, Bethesda, USA). The percentage 
ratio of the newly formed bone area against the total compact 
bone area was analyzed statistically by ANOVA. 
2.4. Statistical analysis 
  Statistical analysis was performed by Statistical Package for 
Social Sciences (SPSS) 16.0 software (SPSS Inc., Chicago, IL, 
United States). In statistical analysis Mann-Whitney U-test, 
Wilcoxon signed ranks test, and Kolmogorov-Smirnov 
test were used for evaluation. Statistical significance was 
assigned to P﹤0.05.
3. Results 
3.1.General observation 
  All animals tolerated the surgical procedures well, and the 
clinical healing process was generally uneventful, with no 
dehiscence of the surgical wound, signs of inflammation, or 
other complications.
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3.2. Radiographic evaluation
 At 4 weeks, a definite defect margin was observed with a 
small amount of radiopacity visible along the lateral margin 
in all the control group specimens; but in the experimental 
group, the defect margin was partially obscured and there were 
irregular and asymmetric radiopaque areas at 0.2-0.4 mm
from the defect margin.
  At 6 weeks, the specimens in the control group seems just 
like the experimental group specimens at 4 weeks; but in 
the experimental group, the defect margins could not be 
distinguished and the radiopaque area extended moderately 
inwards for a uniform distance, even some bony islets that 
were separated from the marginal bone were evident in the 
central area of the defect.
  At 8 weeks, the 1.2 mm and 1.5 mm defects were filled with 
radiopaque substance both in the experimental group and in 
the control group. The 2.0 mm defects in the experimental 
group were almost filled with radiopaque substance except 
in the central portion; but in the control group, only some 
evident bony islets that were separated from the marginal 
bone could be oberved. A bony bridge had formed from the 
marginal bone to the center, and the defect margin was no 
longer defined on all of the 2.5 mm defects (Figure 1). 
1.2 mm           1.5 mm               2.0 mm            2.5 mm
Experimental (4W)
Control (4W)
Experimental (6W)
Control (6W)
Experimental (8W)
Control (8W)
Figure 1.  Radiographic views of the surgical defects at different 
healing periods.
 
3.3. Histologic evaluation
  In all groups, different percentages of connective tissue, 
new bone formation were seen in defected areas. 
  At 4 weeks, in the control group, a small amount of wedge-
shaped bone had regenerated. Most of the newly formed 
bone was woven bone, which showed limited bone marrow 
and a large number of osteoclasts. Bone regeneration in the 
experimental group was slightly greater than the control 
group, and moderate amounts of bone regeneration and bone 
marrow began to appear. Active new bone formation was 
also present, with osteoid seams lined by plump osteoblasts. 
  At 6 weeks, in the control group, bone regeneration was 
significantly greater than that at 4 weeks, and moderate 
amounts of bone regeneration and bone marrow began to 
appear. While in the experimental group the newly formed 
bone had a moderate amount of bone marrow and had 
matured. Bone regeneration from the margin was markedly 
increased in both width and length. Bony islands that 
appeared in some specimens on the center of the defects 
contained moderate amounts of bone marrow. 
  At 8 weeks, in the 1.2 mm and 1.5 mm defects group, 
lamellar bone was formed in the newly formed bone, even in 
the 2.0 mm defects, bony islets. Newly formed woven bone 
had regenerated around the defect margin in the 2.5 mm 
group (Figure 2).
A1 A2 A3 A4
B1 B2 B3 B4
C1 C2 C3 C4
Figure 2.  Low power photomicrograph of new bone formation at 4, 
6, 8 weeks from the calcium citrate group and control group (Original 
magnification10伊, HE staining).
*A(4 week time-point), B( 6 week time-point), C( 8 week time-point).
**The diameter of drilled hole: 1(1.2 mm in experimental group), 
2(2.5 mm in experimental group), 3(1.2 mm in control group), 4(2.5 
mm in control group).
*** Low power photomicrograph of new bone formation in the 
diameter of drilled hole 1.5 mm and 2.0 mm was not showed here.
3.4. Estimated bone area ratio 
  The new bone area ratio at postoperative weeks 4, 6, and 
8 are listed in Figure 3. The mean new bone area ratios of 
the experimental group at 4 weeks were 25.0%, 21.1%, 17.1%, 
and 9.5% in the 1.2, 1.5, 2.0 and 2.5-mm-defect groups, at 6 
weeks were 56.0%, 48.9%, 38.1% and 20.0%, and at 8 weeks 
were 72.6%, 62.1%, 50.3% and 28.0%, respectively. The mean 
new bone area ratios of the control group at 4 weeks were 
21.5%, 16.9%, 14.1% and 7.1% in the 1.2, 1.5, 2.0 and 2.5-
mm-defect groups, at 6 weeks were 51.1%, 46.4%, 34.0% and 
18.1%, and at 8 weeks were 67.8%, 58.1%, 47.5% and 25.4%, 
respectively. The new bone area ratio differed significantly 
between the experimental group and the control group when 
the defects were 1.2 mm and 1.5 mm at 4 and 6 weeks after 
the surgery (P﹤0.05). But there was no significant difference 
among these groups at the 8th week (P>0.05). The estimated 
bone area ratio of (72.60暲3.38)% of calcium citrate Group 
(1.2 mm-defect; 8 weeks) was the highest average value of 
all of the samples. In the 2.5 mm-defect groups, there was 
no significant difference between the experimental group 
and the control group at all healing periods except at the 4th 
week (P﹤0.05). 
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Figure 3.  Estimated bone area ratios by calculation of newly formed 
bone area against total compact bone area after 4-week, 6-week and 
8-week implantation.
Exp: experimental group; Con: control group. 
*: experimental group vs. control group revealed P﹤0.05. 
#: experimental group vs. control group revealed P>0.05.
4. Discussion 
  For bone regeneration and bone tissue engineering 
applications, an ideal biomaterial should have the 
properties of favorable biocompatibility, bioconductivity, 
and biodegradability. An optimal biomaterial used as a 
bone substitute should not only be a temporary scaffold 
for supporting the adhesion, growth, proliferation, and 
differentiation of the 'seed' cells (such as hBMSC), but also 
be able to degrade into  non-toxic products, which can be 
metabolized via the physiological mechanisms[12,13].
  Calcium citrate has the potential to be a well-absorbed 
material that supplies calcium ions to bones, it has been 
used to supply calcium to deficient individuals, especially 
postmenopausal women[14-16], and it was also commonly 
used to prevent or treatment of osteoporosis as calcium 
supplements and could decrease bone loss and increase 
bone mineral density[17]. 
  The present work describes the in vivo behavior of 
calcium citrate for the first time. Radiography, histological 
resultsshowed that the implantation of calcium citrate 
induces a rise in bone formation in the marrow of rabbit 
femur at early phases of fracture healing. The evaluation at 
4th and 6th week showed significant change between the 
experimental group and the control group. Bone marrow 
began to appear and bony islets were observed after 4 weeks 
of healing in the experimental group. The defect closure and 
the new bone area ratio gradually increased with the healing 
time, these parameters differed significantly between 
weeks 4 and 8. An observation period of at least 8 weeks 
was recommended by Bodde et al. A slight increase was 
observed at 8th week but was not statistically significant.
  Bone marrow stromal stem cells (BMSCs) differentiate 
into osteoblasts is the main way for bone formation, it 
follows an orderly cascade of events including proliferation, 
mesenchymal commitment, matrix deposition and matrix 
mineralization. Each of these stages was characterized by 
the expression of lineage-specific genes[18]. As reported in 
many papers, Ca2+ was an extracellular factor that regulated 
viability and osteogenic differentiation of BMSCs. Calcium is 
essential for cells mineralization and elevating concentration 
of Ca2+ slightly would stimulate genes expression associated 
with osteogenesis differentiation including OCN and 
OPN[19,20]. In the previous in vitro studies, it was observed 
that the proliferation and differentiation of BMSCs cultured 
on calcium citrate were significantly enhanced than the 
control. Adluri[21] showed that calcium citrate could 
stimulate the proliferation and mineralization of osteoblast 
cells and increase the activity of ALP significantly, and 
results in this study also confirmed that calcium citrate 
increased the differentiation and proliferation of osteoblasts 
in situ and increased bone formation. 
  Many engineering biomaterials are able to release calcium 
ions, including calcium phosphate and hydroxyapatite, 
which stimulate osteoblast regeneration and proliferation[22-
24]; but these materials resorb more slowly, and the calcium 
ions released is in lower level. This feature may affect new 
bone formed in the early time point. Results in this study 
showed that calcium citrate can stimulate fracture healing 
in Japanese white rabbits in the early time point. The reason 
may be that calcium citrate resorb more faster than calcium 
phosphate, hydroxyapatite and some other biomaterials, so 
the calcium ions released is in higher level. Further study is 
needed to verify this.
  This model has several limitations, and need further 
improved: firstly, the experiment time span is not long 
enough, we should evaluate the experiment result at the 
2th,4th, 8th,12th and 24th weeks postoperatively in order 
to better observe the effect of calcium citrate on bone 
integration in a rabbit femur defect. Secondly, "critical size 
defects (CSD)" is mentioned in many animal experiment. 
The CSD has been defined as the smallest intraosseous 
wound in an animal that will not heal spontaneously when 
left untreated for a certain time period[25] or which shows 
less than 10% bone regeneration during the lifetime of 
the animal[26]. The CSD has been used as an experimental 
model for evaluating the effectiveness of newly developed 
biomaterials[27]. The experiment is not designed according 
to the CSD, so it increases the difficulty of dealing with 
our post-experiment result. Furthermore, further studies 
should be performed to compare calcium citrate with other 
bone substitutes, and possibly in combination with other 
osteogenic proteins or growth factors.
  Citric acid reacts with many ceramic materials, such as HA, 
which have been designed and surface-treated to promote 
cell adhesion[28,29]. Calcium citrate had not been used as a 
bone graft material, simply because it is difficult to shape in 
order to provide long-term three-dimensional framework, 
although calcium citrate is rapidly resorbed in vivo releasing 
calcium ions for the new bone formation. 
  Future studies examining how to make calcium citrate 
shaped and what,s the biologic response of this material in 
other bony sites may reveal further insight into their future 
clinical use, Of course, there is still a long way to go.
  In summary, the present study reveals that calcium citrate 
affected positively the early periods of fracture healing 
mechanism in Japanese white rabbits, especially when 
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the defect is not too large. But the specific mechanism 
for calcium citrate to stimulate bone formation is unclear. 
We think that more evidences are required for the better 
understanding of potential of calcium citrate at the treatment 
of intrabony defects.
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